J9048 HCPCS Level II code: Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg
J9048 is the HCPCS code for “Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9048Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg
Short description: Inj, bortezomib freseniuskab
HCPCS · United States
Medicare details
The indicators CMS publishes with J9048 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 2023
Where J9048 sits
- 1J codesDrugs administered other than orally
- 2Active code J9048Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9048 mean?
J9048 is the HCPCS code for “Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9048?
CMS lists J9048’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9048
All J codesJ9042Injection, brentuximab vedotin, 1 mgJ9043Injection, cabazitaxel, 1 mgJ9044Injection, bortezomib, not otherwise specified, 0.1 mgJ9045Injection, carboplatin, 50 mgJ9046Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mgJ9047Injection, carfilzomib, 1 mgJ9049Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mgJ9050Injection, carmustine, 100 mgJ9051Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mgJ9052Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mgJ9053Injection, belantamab mafodotin-blmf, 0.1 mgJ9054Injection, bortezomib (boruzu), 0.1 mg